Article
MetALD: Genetic Factors and Clinical Outcomes.
Seminars in liver disease - 1 Sept 2025
Israelsen Mads, Trépo Eric, Krag Aleksander, Stender Stefan
Abstract excerpt
Metabolic and alcohol-related liver disease (MetALD) is a subcategory of steatotic liver disease (SLD) characterized by the coexistence of cardiometabolic risk factors and elevated alcohol intake. The global prevalence of MetALD is estimated to be 2 to 5%, but this is likely underestimated due to self-reporting biases. In real-world settings, fluctuations in alcohol intake mean that many patients with SLD may be...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
